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Abstract
Dysphagia is associated with increased risk of stroke-associated pneumonia (SAP). However, it is unclear what other factors 
contribute to that risk or which measures may reduce it. This systematic review aimed to provide evidence on interventions 
and care processes associated with SAP in patients with dysphagia. Studies were screened for inclusion if they included 
dysphagia only patients, dysphagia and non-dysphagia patients or unselected patients that included dysphagic patients and 
evaluated factors associated with a recorded frequency of SAP. Electronic databases were searched from inception to February 
2017. Eligible studies were critically appraised. Heterogeneity was evaluated using I2. The primary outcome was SAP. Eleven 
studies were included. Sample sizes ranged from 60 to 1088 patients. There was heterogeneity in study design. Measures 
of immunodepression are associated with SAP in dysphagic patients. There is insufficient evidence to justify screening for 
aerobic Gram-negative bacteria. Prophylactic antibiotics did not prevent SAP and proton pump inhibitors may increase risk. 
Treatment with metoclopramide may reduce SAP risk. Evidence that nasogastric tube (NGT) placement increases risk of SAP 
is equivocal. A multidisciplinary team approach and instrumental assessment of swallowing may reduce risk of pneumonia. 
Patients with impaired mobility were associated with increased risk. Findings should be interpreted with caution given the 
number of studies, heterogeneity and descriptive analyses. Several medical interventions and care processes, which may 
reduce risk of SAP in patients with dysphagia, have been identified. Further research is needed to evaluate the role of these 
interventions and care processes in clinical practice.
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Introduction
Stroke-Associated Pneumonia (SAP) is common post 
stroke affecting 14% of patients [1], and is associated with 
increased risk of in hospital mortality [2], prolonged length 
of hospital stay [3], and has considerable economic impact 
on healthcare resources [4]. The pathophysiology of SAP is 
multifactorial. The combination of stroke-induced immuno-
deficiency and aspiration of oropharyngeal secretions and 
gastric contents into the lungs related to impaired conscious-
ness and dysphagia predisposes patients to SAP in the first 
few days post stroke [5]. Respiratory tract infections may 
also precede stroke thereby contributing to stroke etiopatho-
genesis [6].
Acute stroke impairs the peripheral immune system, 
which is mediated by over-activation of the sympathetic 
nervous system and hypothalamic–pituitary–adrenal 
axis. Inhibition of peripheral cellular immune responses 
is characterized by transient lymphopenia and monocyte 
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deactivation, which increases susceptibility to infection 
[7]. In a murine model of human stroke, stroke mice 
developed pan-lymphocytopenia and lymphocyte apop-
tosis in lymphoid tissues, which was reversed by either 
β-adrenergic receptor blockade or glucocorticoid recep-
tor inhibition [8]. Alteration of tracheal epithelium caused 
by stroke immunomodulation has been shown to impair 
pulmonary clearance [9]. Reduced pulmonary clearance 
and impaired mobility related to decreased airway entry 
and impaired drainage of secretions from the lungs may 
contribute to development of pneumonia [9, 10].
Patients with dysphagia are more than three times at 
risk of developing pneumonia after stroke and the risk 
increases 11-fold in patients with confirmed aspiration 
[11]. Early dysphagia screening and specialist swallow 
assessment by a speech and language pathologist (SLP) 
may reduce the risk of SAP [12]. However, patients who 
are exclusively fed via the enteral route are also at risk of 
developing SAP. Tube feeding [13] and poor oral hygiene 
[14] may increase the risk of pneumonia by promoting 
bacterial colonization of the oropharynx. The presence of 
oral and dental disease causes alterations of oropharyn-
geal flora, and reduced saliva flow increases the bacterial 
density of the saliva. The presence of a nasogastric tube 
(NGT) may impact on bacterial colonization due to forma-
tion of biofilms on the tube [13], and predispose patients 
to gastro-esophageal reflux and vomiting [15]. Aspiration 
of bacteria laden secretions and infected refluxed material 
increases the risk of pneumonia. Functional status such as 
dependence for oral care and feeding has been shown to 
be significantly associated with respiratory infection [16].
A range of factors may be associated with SAP. These 
include risk factors associated with patient characteristics 
such as age, stroke severity, level of consciousness, as well 
as co morbidities such as chronic obstructive pulmonary 
disease and coronary artery disease [17]. However, these 
risk factors are outside the scope of this review. For this 
review, factors were defined as medical interventions to 
manage physiological status and care processes systemic 
to patients with dysphagia, in acute phase stroke and were 
identified from references and citation searching from a 
precursory systematic review [12].
The role of these pathophysiological processes in con-
tributing to SAP in stroke patients with dysphagia, and the 
potential for therapeutic interventions to prevent SAP, is 
not well understood. We therefore undertook a systematic 
literature review with the aim of identifying care processes 
and/or interventions that were associated with modified 
risk of SAP in patients with dysphagia in acute stroke as 
targets for future clinical trials and evidence for implemen-
tation of a care process or intervention.
Methods
Search Strategy and Selection Criteria
A systematic review was undertaken according to the 
Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) statement [18], and Centre 
for Reviews and Dissemination guidance [19]. A build-
ing block [20] approach identified search terms for each 
concept. The concepts were dysphagia (Concept A), stroke 
(Concept B), risk factors (Concept C) and SAP (Concept 
D). These were combined using the Boolean AND opera-
tor. Two search strategies were used to develop the search 
terms: National Clinical Guideline for Stroke [21] and the 
Pneumonia in Stroke Consensus (PISCES) Group [22]. 
Co-authors (SP, KS, MG) reviewed the search strategy 
(Electronic Supplementary Material). Electronic databases 
were searched from inception to 14/2/2017 for relevant 
studies: CINAHL (via EBSCOhost), COCHRANE (via 
Wiley Online), EMBASE (via NICE Healthcare Data-
bases), MEDLINE (via EBSCOhost) and SCOPUS. In 
addition, references and citations of included studies were 
screened. An example of the search strategy for the MED-
LINE search is included in the Supplementary Material 
(Table1).
The review was restricted to peer-reviewed English lan-
guage stroke research. Studies of dysphagia only patients, 
studies comparing dysphagia and non-dysphagia patients 
and unselected patients that reported dysphagia and evalu-
ated factors associated with a recorded frequency of SAP 
were included. Acute phase stroke is typically defined 
as ≤ 72 h from admission. The time restriction of ≤ 72 h 
might not be explicit in the title/abstract; therefore, if the 
abstract met all the other inclusion criteria, it was included 
in the next stage of the screening process. Non-stroke or 
mixed population studies, those of exclusively intubated 
and mechanically ventilated patients, and studies not doc-
umenting SAP or pneumonia post stroke or pre-existing 
pneumonia were excluded.
Medical interventions included NGT feeding, oral care 
and prophylactic measures, for example, screening for 
immunodepression, antibiotics, management of gastro-
esophageal reflux and the use of angiotensin-converting 
enzyme (ACE) inhibitors which have been suggested 
to reduce risk of pneumonia [23, 24]. Care processes 
included positioning, mobilization and staff competences 
and adherence to safe swallowing techniques. The primary 
outcome of interest was SAP. SAP is defined as the spec-
trum of lower respiratory tract infections within the first 
7 days after stroke onset [22]. However, given the variation 
in reporting of post-stroke pneumonia and difficulty estab-
lishing stroke onset in some patients, for the purpose of 
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this review studies were included that reported pneumonia 
within hospitalization and ≤ 30 days of stroke onset.
Two authors independently applied the inclusion/exclu-
sion criteria to titles and abstracts for eligibility (Supple-
mentary Material Table 2). Differences were forwarded to 
a third author for consensus. Abstracts that met the inclu-
sion criteria were recommended for full-text reading and 
assessed by SAE. Corresponding authors were contacted 
to resolve eligibility and/or data extraction issues.
Data Abstraction and Analysis
SAE designed and piloted a data extraction form based on 
Royal College of Physicians National Clinical Guideline 
for Stroke [25] and independently extracted data for the 
titles. Data extraction included study design, baseline char-
acteristics of the population, factors and association with 
SAP (Supplementary Material Tables 3–4). Authors were 
contacted if data were not available. The extracted results 
were synthesized into the defined groups and organized 
thematically based on the National Clinical Guideline for 
Acute stroke care [21].
Risk of Bias
Randomized control trials (RCTs) were assessed for risk 
of bias and quality [26]. Risk of bias tables were used to 
describe the methods used in each study and whether the 
results were at risk (Supplementary Material Table 5). Non-
RCTs were assessed using the Critical Appraisal Skills Pro-
gramme (CASP) checklists [27].
Statistical Analysis
Inter-rater reliability for the inclusion/exclusion criteria was 
analysed using the Kappa statistic. The percentage of varia-
tion across studies due to heterogeneity was evaluated using 
I squared (I2) [28]. Review Manager 5.3 [29] and Microsoft 
Excel produced forest plots for illustration only [30].
Results
Database searching found 1326 references and 12 arose 
through other sources (Fig. 1). Inter-rater reliability for 
the inclusion/exclusion criteria was 0.78. Thirty-one full-
text articles were assessed for eligibility. Eleven studies of 
Fig. 1  Search methodology and 
outcome
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10 ischemic and hemorrhagic stroke patient cohorts were 
included (Table 1). Kalra et al. [31] and Kalra et al. [32] used 
the same RCT data. Study designs included RCTs (30%) [15, 
31-33], prospective (20%) [13, 34] and retrospective (40%) 
[35-38] observational studies and one quasi-experimental 
design [39]. Europe hosted 55% of studies [15, 31–34, 37], 
Australia 27% [13, 36, 38] and Japan 18% [35, 39]. Five 
studies included dysphagia only populations [15, 31, 32, 35, 
37], 2 studies included patients with and without dyspha-
gia [33, 34], and 4 were unselected [13, 36, 38, 39]. There 
was variation in the way participant characteristics such as 
National Institutes of Health Stroke Scale (NIHSS) and age 
were reported and missing information. Based on available 
data, the overall mean NIHSS score was 12 [15, 31, 32, 34, 
35, 37, 39] and mean age of participants was 76 years [15, 
31, 32, 34, 35, 37-39].
Assessment of Quality And Bias
Study quality ranged from high-quality RCTs to moderate 
quality quasi-experimental studies to lower quality retro-
spective observational studies (Supplementary Material 
Table 4). Overall, the RCTs were deemed to have a low risk 
of bias. Potential sources of selection bias in the cluster RCT 
studies [31, 32] included where patients at increased risk of 
SAP might have been preferentially recruited into the inter-
vention group. A limitation of the Kalra et al. [31] study 
was that data were derived from an RCT and a prospective 
cohort data structure was assumed, which may have resulted 
in selection bias. A possible source of performance bias was 
participants and researchers being aware of allocation treat-
ment. The open intervention allocation could potentially 
influence physician diagnosis of pneumonia.
Other possible sources of bias and quality considerations 
in the RCT and non-RCT studies include small population 
size and risk of measurement bias. There was a lack of objec-
tive measurement of the MDT swallowing approach [39] and 
the potential bias of progressive proficiency of implement-
ing the MDT protocol over time [37]. Other examples of 
measurement bias included lack of information about the 
diagnosis and method of assessment of dysphagia and sub-
sequent measurement and severity rating, and classification 
of stroke severity.
Diagnosis and Frequency of SAP
Overall incidence was reported in 10 studies [13, 15, 31-36, 
38, 39] (Supplementary Material Table 5, Fig. 1) and ranged 
from 3.9 to 56.7% [15, 33], with the largest dataset at 11.3% 
[31, 32]. The Centers for Disease Control and Prevention 
(CDC) criteria [40] were used to define pneumonia in the 
majority of studies. One study made a diagnosis based on 
the British Thoracic Society recommendations [15]. The 
STROKE-INF trial data set used blinded application of 
CDC criteria and physician-diagnosed pneumonia [31, 32]. 
Four used a combination of clinical symptoms, radiologic 
findings on X-ray and laboratory results and combined anti-
biotics [13, 15, 33, 37]. Two studies provided no definition 
[36, 38].
Measurement of pneumonia timing varied. Four stud-
ies reported pneumonia during hospitalization [33, 34, 
37, 39]. Three studies reported within 14 days of admis-
sion [31, 32, 35] and one from 7 days of admission [36]. 
Warusevitaine et al. [15] and Langdon et al. [13] reported 
at 21 days and 30 days, respectively. Schwarz et al. [38] did 
not report the period of diagnosis. Marked variation in study 
design and reporting of participant characteristics prohibited 
meta-analysis.
Medical interventions
Prophylactic Measures
Screening for  Stroke‑Induced Immunodepression One 
study [34] investigated the predictive properties of biomark-
ers of immunodepression (mHLA-DR expression), as well 
as inflammation (IL-6), and infection (LBP) during the 
acute phase of stroke, and incidence of SAP stratified for 
patients with and without dysphagia.
Incidence and risk of SAP Incidence of SAP in patients 
with dysphagia was 16.2% vs. 5.2% overall. When combin-
ing all three biomarkers and presence of dysphagia, only 
mHLA-DR [OR 0.29 (95% CI 0.09–0.94; p = 0.0398)] and 
dysphagia [OR 5.74 (95% CI 2.21–14.89; p = 0.0003)] were 
independent predictors of SAP. Patients with dysphagia and 
low mHLA-DR expression were at particularly high risk of 
SAP (18.8%). In patients without dysphagia and who had 
normal mHLA-DR expression, no SAP was observed (0%).
Medication Use Four studies investigated use of pharma-
cological agents for reducing pneumonia: prophylactic 
antibiotics [32], acid suppressive medications [35], meto-
clopramide—an antiemetic and prokinetic drug [15], and 
selective decontamination of the digestive tract (SDD) [33]. 
No studies assessed ACE inhibitors and their association 
with SAP in patients with dysphagia. Three studies were 
RCTs [15, 32, 33]. Preventative antibiotics were adminis-
tered in Nil by mouth (NBM) patients ≤ 48 h post onset of 
stroke symptoms [32]. In a second study, patients who were 
unable to eat orally for 14 days or more after admission were 
exposed to acid suppressive drugs: famotidine, a Histamine 
H2-Blocker (H2B), and omeprazole, a Proton Pump Inhibi-
tor (PPI) [35]. The choice of drugs was at the discretion of 
the treating physician. Warusevitaine et al. [15] study par-
ticipants received metoclopramide or placebo 3× daily via 
the NGT for 21  days or until NGT feeds were discontin-
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ued. SDD involved oral gel containing antimicrobial drugs, 
applied topically to the mouth four times daily. Patients were 
randomized to receive either the SDD gel or placebo. Treat-
ment was continued for 3 weeks for patients with dysphagia 
and for 2 weeks for those with a normal swallow.
Incidence and risk of SAP Kalra et al. [32] found that 
prophylactic antibiotics did not affect the incidence of 
algorithm-defined post-stroke pneumonia in the antibiotic 
group (13%) versus the control group (10%) (aOR 1.21; 
95% CI 0.71–2.08, p = 0.489). Additionally, no differ-
ences were noted in physician-diagnosed post-stroke pneu-
monia between dysphagic patients in the antibiotic group 
(16%) versus the control group (15%) (aOR 1.01; 95% CI 
0.61–1.68, p = 0.957).
Arai et al. [35] found that the daily incidence of pneu-
monia in the PPI group (6.38%, 95% CI 3.78–10.1) was 1.7 
times higher than in the exposed H2B group (3.77%, 95% 
CI 2.92–4.78). PPI use in patients with dysphagia was asso-
ciated with increased risk of pneumonia (RR 2.00, 95% CI 
1.12–3.57), while use of H2B was not (RR 1.24, 95% CI 
0.85–1.81).
Warusevitane et al. [15] found there were significantly 
more episodes of pneumonia in the placebo group (RR 5.24, 
95% CI 2.43–11.27; p < 0.001) than the metoclopramide 
group: placebo group mean 1.33 (SD 0.76) vs. metoclopra-
mide group mean 0.27 (SD 0.45).
In Gosney et al. [33], 3.94% (N = 8) patients developed 
pneumonia. Seven of the 8 cases of pneumonia occurred in 
patients with dysphagia. Patients with dysphagia were twice 
as likely to have AGNB (aerobic Gram-negative bacteria) 
organisms, which are implicated in aspiration pneumonia, 
present in their first swab (< 24 h of admission) than those 
with a normal swallow, although this did not reach signifi-
cance. Only 1 dysphagic patient treated with SDD developed 
pneumonia compared to 6 dysphagic patients in the placebo 
group. The study did not provide data on how many dys-
phagic patients with AGNB developed pneumonia compared 
to those with dysphagia without AGNB.
Nasogastric Tubes (NGTs) Four studies [13, 31, 36, 38] 
investigated association between NGTs and SAP in acute 
stroke patients. The characteristics of these studies varied 
between unselected patients that included patients with dys-
phagia [13, 36, 38] and dysphagia only patients [31]. Kalra 
et  al. [31] used the STROKE-INF data set where patients 
had been randomly assigned to be given either prophylactic 
antibiotics or standard stroke unit care. Three studies pro-
vided experimental and control data [13, 31, 36].
Incidence and risk of SAP Overall incidence of SAP var-
ied between and within studies. Brogan et al. [36] (37%) and 
Langdon et al. [13] (41%) reported higher incidence of SAP 
compared to Kalra et al. who reported rates of incidence 
for physician-diagnosed (18.5% vs. 15.3%, p = 0.21) and 
algorithm-defined SAP in NGT-fed and No-NGT patients 
(14.4% vs. 10.1%, p = 0.046). The higher rate of algorithm 
SAP in patients with NGT did not remain significant after 
adjustment for age, stroke type, severity and chronic lung 
disease (aOR 1.26; 95% CI 0.78–2.03, p = 0.35). Patients 
with NGT had more severe strokes with impaired conscious-
ness. Preventive antibiotics did not reduce incidence of 
SAP in patients with NGT [aOR 1.05 (95% CI 0.73–1.52); 
p = 0.803]. Schwartz et al. [38] did not report incidence of 
SAP in patients with NGT and did not respond to informa-
tion requests by the author. Differences in SAP incidence 
between studies can be partly explained by the different 
study populations and the lack of adjustment for stroke 
severity and baseline characteristics [13, 36].
There was a high degree of heterogeneity between the 
three studies (I2 = 94%) [13, 31, 36] that provided experi-
mental (NGT) vs. control (No NGT) data. The incompat-
ibility of study designs precluded presenting the data as a 
meta-analysis. Based on the individual studies, Kalra et al. 
found no evidence that NGT increased SAP (aOR 1.26; 95% 
CI 0.78–2.03, p = 0.35). In contrast, Brogan et al. found hav-
ing an NGT (OR 3.91; 95% CI 1.73–8.80; p = 0001) and 
being NBM (OR 5.62; 95% CI 1.54–20.46; p = 0.0089) were 
independently associated with respiratory infections. Lang-
don et al. also found being enteral fed during admission was 
a significant risk factor for respiratory infection (aRR 2.76; 
95% CI 1.26–6.01, p value 0.011). Schwarz et al. found the 
presence of an NGT significantly increased the risk of devel-
oping aspiration pneumonia (p < 0.0001) with a relative risk 
of 12.609 (95% CI, OR 21.54).
Care Processes
Multidisciplinary Team Approach (MDT) To Swallowing
Two studies described the implementation of a MDT 
approach to dysphagia, in dysphagia only [37] and unse-
lected patients [39]. Aoki et al. MDT participatory team 
comprised of 9 professionals including doctors, dentists, 
nurses, physiotherapists (PT), occupational therapists (OT), 
SLPs, managerial dieticians, dental hygienists and phar-
macists. The approach was the cooperation of the various 
professionals that have the skills to improve the quality of 
medical care, utilizing the specialist knowledge and skills of 
each professional. To understand the difference of the MDT 
approach, frequencies of professional oral care and swal-
lowing evaluations before team organization (‘prior period’) 
and the period after team organization (‘post period’) were 
evaluated.
In Gandolfi et al. [37], a standardized diagnostic and reha-
bilitative protocol for stroke related dysphagia management 
was progressively introduced. A MDT of neurologists, nurses, 
rehabilitation physicians, PTs, nutritionist, SLPs, radiologists 
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and ear nose throat specialists were involved in the implemen-
tation. The protocol consisted of 2 phases: a diagnostic phase, 
aiming to define the swallowing problem and selecting those 
patients who were eligible for the following rehabilitative 
phase. The diagnostic phase included clinical and instrumental 
evaluation by fiber-optic endoscopic evaluation (FEES) and/or 
videofluoroscopy (VFSS). Rehabilitative treatment for dyspha-
gia proceeded in 3 consecutive phases: Phase 1 sensory stimu-
lation of the oral cavity, oro-facial and breathing exercises, 
Phase 2 swallowing trials of crushed iced and jellied water 
and teaching airway protection strategies and Phase 3 weaning 
from nutritional support by administration of small semisolid 
meals fractionated throughout the day. During hospitalization 
the patients received 1-hour individual sessions of rehabilita-
tion for dysphagia. Pneumonia rates were compared after pre 
implementation of the protocol for dysphagia (T− group) ver-
sus after the implementation of the MDT protocol (T+  group).
Incidence and  Risk of  SAP Aoki et  al. found pneumonia 
onset was less frequent in the post group compared to the 
prior group (6.9% vs. 15.9%; p = 0.01) and a MDT swallow-
ing approach was related to reduced occurrence of pneumo-
nia onset independent of NIHSS score on admission (aHR 
0.41, 95% CI 0.19–0.84, p = 0.02). The percentage of patients 
receiving professional oral care (51.7% vs. 12.9%, p < 0.0001) 
and instrumental swallowing evaluations (26.0% vs. 12.1%, 
p  =  0.002) were significantly increased in the post group. 
Gandolfi et al. reported no significant differences between the 
two groups in the frequency of pneumonia but did not provide 
incidence data. There was very weak evidence of a reduction 
in pneumonia risk for the T+ group [aOR 0.34 (0.07–1.49)] 
compared to the T− group.
Mobility
Two studies, both of unselected patients investigated reduced 
mobility and the impact on SAP [13, 36].
Incidence and  Risk of  SAP Both studies found patients 
who required full assistance with mobility or had impaired 
mobility on admission were at significant risk of SAP. Bro-
gan et al. [36] found odds of infection were 6.48 times (95% 
CI 1.35–31.16; p = 0.0198) for patients who required full 
assistance with mobility than those who were able to mobi-
lize. Langdon et al. found impaired mobility on admission 
was a significant risk factor for respiratory infection (aRR 
2.86; 95% CI 1.26–6.48, p value 0.012) [13].
Other Care Processes
No studies were retrieved from the search strategy relating 
to positioning or adherence with recommendations from the 
dysphagia screen or specialist swallow assessment.
Discussion
We have identified a range of medical interventions and 
care processes, which may impact on the development 
of SAP in patients with dysphagia. However, there are 
insufficient data to recommend any of these at present and 
interpretation is limited by heterogeneity of studies and 
reporting. This review has identified a need for further 
research of candidate processes and interventions.
There is emerging evidence for the use of preventative 
measures such as screening for stroke-induced immuno-
suppression and considering instrumental swallow assess-
ment in patients with low mHLA-DR expressions who 
have been identified with dysphagia. Further RCTs with 
larger sample sizes are needed to test this hypothesis and 
screening for AGNB organisms. Studies need to evaluate 
the utility and external validity of these medical interven-
tions specifically in relation to optimal timing, point-of-
care technology, and what they add to existing dysphagia 
assessment methods. Further research is also required 
to evaluate what the intervention might be, for example 
boosting the immune system in the acute phase, or treating 
with SDD gel for the duration of the patients’ dysphagia.
The findings of Kalra et al. [32] are consistent with a 
recent Cochrane Review [41] which found high-quality 
evidence that antibiotic prophylaxis in people with acute 
stroke does not reduce post-stroke pneumonia (RR 0.95, 
95% CI 0.80–1.13). The PRECIOUS (PREvention of Com-
plications to Improve OUtcome in elderly patients with 
acute Stroke) Trial is assessing if metoclopramide prevents 
aspiration [42]. This has the potential to inform whether 
the use of metoclopramide can reduce risk of pneumonia 
shown by Warusevitaine et al. The one study included in 
this review found that PPI use in non-orally fed patients 
was significantly associated with increased risk of pneu-
monia while H2B was not, suggesting PPI may have to 
be avoided in those at high risk for pneumonia. There is 
equivocal evidence that NGT placement increases risk of 
SAP due to high degree of heterogeneity between studies. 
Further studies are needed to evaluate if treatment with 
H2B and PPI, and NGT use are implicated in the risk of 
SAP in patients with severe dysphagia.
A number of studies support the argument for a criti-
cal period of susceptibility for post-stroke infection [13, 
15, 34, 36]. Warusevitaine et al. found of the patients that 
developed pneumonia, for 94% of patients this occurred 
within 7 days post admission; the mean time from NGT 
insertion to the first episode of pneumonia was 4 days in 
the treatment group and 2 days in the placebo group. Lang-
don et al. propose to hold off institutional enteral feeding 
for the first 3–4 days concentrating on maintaining hydra-
tion via intravenous or sub-cutaneous methods suggesting 
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this may reduce the risk of post-stroke infection from 
stroke-induced immunodeficiency and allow spontaneous 
recovery of swallow function.
Both studies evaluating a MDT approach [37, 39] to 
swallowing management found this impacted positively on 
reducing risk of incidence of SAP. This supports previous 
studies that have demonstrated an integrated team approach 
and dysphagia clinical pathway has a positive impact on 
rates of pneumonia [43-47]. However, Aoki et al. lacked 
clarity about what the intervention involved. Improvement 
in pneumonia rates was attributed to increased oral care by 
dental professionals and instrumental assessments by SLPs, 
and the creation of appropriate dysphagia diets and nutri-
tional supplements by dieticians. Similarly Gandolfi et al. 
lacked detail about what components of the intervention 
had a positive impact on patient outcomes. Both studies 
used either FEES and/or VFSS instrumental assessments 
and emphasized the cooperation and utilization of different 
professionals. Additionally, the inclusion of an evaluation of 
postural control by Gandolfi et al. may have been a contribu-
tory factor to the success of the MDT management. How-
ever, it might be argued that in the Gandolfi study, dysphagia 
received greater attention in the T+ group with the imple-
mentation of the specific protocol rather than the protocol 
itself. The study also did not necessarily apply typical care 
routines within their teams, for example the rehabilitation 
physician rather than the SLP undertook the clinical bedside 
swallow assessment.
This review acknowledges certain limitations. There is a 
risk of selection bias. Studies were identified based on the 
selection criteria. We acknowledge that there are other stud-
ies that include dysphagic patients within unselected trial 
populations but because they did not report data specifically 
for this population, they were not retrieved by our search. 
For example, Anderson et al. [48] examined whether lying 
flat versus sitting up at least 30 degrees as an early interven-
tion in stroke care would improve outcomes in patients with 
ischemic stroke. There was no difference between the two 
groups in mortality (7.3% lying flat vs. 7.4% sitting up) or 
major disability (mRS 4–6) (38.9% lying flat vs. 39.7% sit-
ting up). There was no significant between-group difference 
in the rate of pneumonia. However, data for patients with 
dysphagia were not reported which meant that this study 
would not have been retrieved by the search strategy. In this 
study, patients with a definite clinical indication or contrain-
dication of being laid flat were excluded, such that patients 
with severe dysphagia may have been excluded. Other exam-
ples of selection bias were that only a small number of stud-
ies were identified which met the inclusion criteria for each 
factor and in some cases no relevant studies were found.
The pathoetiology of SAP is a combination of stroke-
induced suppression of immune responses and pulmo-
nary infectious challenge as a consequence of aspiration 
of oropharyngeal secretions and gastric contents into the 
lungs in the first few days post stroke. The Pneumonia in 
Stroke Consensus (PIECES) group defines SAP as a spec-
trum of lower respiratory infections within the first 7 days 
after stroke onset and diagnosis of SAP are based on the 
Centers for Disease Control and Prevention (CDC) criteria 
[22]. Examples of reporting bias include variation in the 
diagnostic criteria for SAP and the period of diagnosis in 
the included studies. There may also be the possibility that 
non-infective causes of lung inflammation (e.g. pneumonitis) 
may have been reported as pneumonia. Further examples of 
reporting bias include the lack of information on the diag-
nosis and method of assessment of dysphagia and measure 
of severity. Therefore, the findings need to be interpreted 
with caution.
A further limitation was the sole use of British orthogra-
phy for terms “oesophageal” and “GORD”. This may have 
precluded identification of some records using the American 
orthography. The use of the MeSH term “deglutition disor-
ders” should have limited the impact of this omission.
Conclusion
This review has shown SAP is associated with a range of 
interventions and care processes and there is increased sus-
ceptibility in the acute phase for patients with dysphagia. 
Measures of immunodepression are associated with SAP in 
dysphagic patients. However, there is insufficient evidence 
to suggest screening for immunosuppression at this stage. 
There is absence of evidence that prophylactic antibiotics 
make a difference to pneumonia rates in patients with dys-
phagia and use of PPIs may be associated with increased 
risk. There is insufficient evidence to justify screening for 
aerobic Gram-negative bacteria. Treatment with metoclo-
pramide may reduce SAP risk. A multidisciplinary team 
approach and instrumental assessment of swallowing may 
reduce risk of pneumonia. The evidence that NGT placement 
increases risk of SAP is equivocal. Impaired mobility is 
associated with increased risk. Further studies should exam-
ine these factors and the potential to reduce the incidence of 
SAP in patients with dysphagia using instrumental methods 
of assessment and standardized measurement criteria.
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